Teva says Israel-Hamas war not hurting production, eyes growth in 2024 | Reuters
Teva names Richard Francis as new CEO after Kåre Schultz departure | Ctech
Teva's new CEO Schultz to take post Wednesday | The Times of Israel
Teva paid top executives $330m while share price tanked - Globes
Teva has made short work of its hunt for a new CEO
Teva Pharmaceutical Names Richard Francis as CEO, President - WSJ
The U.S. Opioid Abuse Lawsuits Are Political, Says Teva CEO | Ctech
Teva CEO Richard Francis on Q2 earnings beat
Teva Pharma CEO Richard Francis on Q4 earnings
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Chairman of pharmaceutical giant Teva to resign | The Times of Israel
Watch CNBC's full interview with Teva Pharmaceuticals CEO Kare Schultz - YouTube
Teva CEO Steps Down After Patent Losses, Bribery Settlement; Stock Dives | Stock News & Stock Market Analysis - IBD
Teva Pharmaceuticals appoints Richard Francis CEO | HealthCare Middle East & Africa Magazine
Tel Aviv-based Teva CEO: Our manufacturing is unaffected as it stands
Teva stock pops on Q2 results, CEO sees 'significant' potential for trio of branded drugs
Teva CEO steps down, replacement found — MedWatch
It wasn't easy': Erick Roche on steering Teva France through media storm – European CEO
CEO of drug maker Teva out ahead job cuts (Update)
Teva CEO Kare Schultz Says Drugmaker Will Fight US Price-Fixing Charges - Bloomberg
Teva's Richard Francis launches 'pivot to growth' strategy | Fox Business Video
